Cargando…

Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist

Labeled with carbon‐11, N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐methoxyphenyl)‐N′‐methylguanidine ([(11)C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion‐channel site of N‐methyl‐D‐aspartate (NMDA) receptors in human imaging studies. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Metaxas, Athanasios, van Berckel, Bart N. M., Klein, Pieter J., Verbeek, Joost, Nash, Emily C., Kooijman, Esther J. M., Renjaän, Véronique A., Golla, Sandeep S. V., Boellaard, Ronald, Christiaans, Johannes A. M., Windhorst, Albert D., Leysen, Josée E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381215/
https://www.ncbi.nlm.nih.gov/pubmed/30784206
http://dx.doi.org/10.1002/prp2.458
_version_ 1783396466588385280
author Metaxas, Athanasios
van Berckel, Bart N. M.
Klein, Pieter J.
Verbeek, Joost
Nash, Emily C.
Kooijman, Esther J. M.
Renjaän, Véronique A.
Golla, Sandeep S. V.
Boellaard, Ronald
Christiaans, Johannes A. M.
Windhorst, Albert D.
Leysen, Josée E.
author_facet Metaxas, Athanasios
van Berckel, Bart N. M.
Klein, Pieter J.
Verbeek, Joost
Nash, Emily C.
Kooijman, Esther J. M.
Renjaän, Véronique A.
Golla, Sandeep S. V.
Boellaard, Ronald
Christiaans, Johannes A. M.
Windhorst, Albert D.
Leysen, Josée E.
author_sort Metaxas, Athanasios
collection PubMed
description Labeled with carbon‐11, N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐methoxyphenyl)‐N′‐methylguanidine ([(11)C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion‐channel site of N‐methyl‐D‐aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([(3)H]GMOM). The binding properties of [(3)H]GMOM were compared to those of the reference ion‐channel ligand [(3)H](+)‐dizocilpine maleate ([(3)H]MK‐801), in a set of concentration‐response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70‐fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration‐response assays, the binding of [(3)H]GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [(3)H]MK‐801. Scatchard transformation of homologous inhibition data produced concave upward curves for [(3)H]GMOM and [(3)H]MK‐801. The radioligands showed bi‐exponential association kinetics in the presence of 100 μmol L(−1) l‐glutamate/30 μmol L(−1) glycine. [(3)H]GMOM (3 nmol L(−1) and 10 nmol L(−1)) was inhibited with dual affinity by (+)‐MK‐801, (R,S)‐ketamine and memantine, in both presence and absence of agonists. [(3)H]MK‐801 (2 nmol L(−1)) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, with an IC(50) value of ~19 nmol L(−1). The non‐linear Scatchard plots, biphasic inhibition by open channel blockers, and bi‐exponential kinetics of [(3)H]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [(11)C]GMOM are discussed.
format Online
Article
Text
id pubmed-6381215
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63812152019-07-08 Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist Metaxas, Athanasios van Berckel, Bart N. M. Klein, Pieter J. Verbeek, Joost Nash, Emily C. Kooijman, Esther J. M. Renjaän, Véronique A. Golla, Sandeep S. V. Boellaard, Ronald Christiaans, Johannes A. M. Windhorst, Albert D. Leysen, Josée E. Pharmacol Res Perspect Original Articles Labeled with carbon‐11, N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐methoxyphenyl)‐N′‐methylguanidine ([(11)C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion‐channel site of N‐methyl‐D‐aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([(3)H]GMOM). The binding properties of [(3)H]GMOM were compared to those of the reference ion‐channel ligand [(3)H](+)‐dizocilpine maleate ([(3)H]MK‐801), in a set of concentration‐response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70‐fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration‐response assays, the binding of [(3)H]GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [(3)H]MK‐801. Scatchard transformation of homologous inhibition data produced concave upward curves for [(3)H]GMOM and [(3)H]MK‐801. The radioligands showed bi‐exponential association kinetics in the presence of 100 μmol L(−1) l‐glutamate/30 μmol L(−1) glycine. [(3)H]GMOM (3 nmol L(−1) and 10 nmol L(−1)) was inhibited with dual affinity by (+)‐MK‐801, (R,S)‐ketamine and memantine, in both presence and absence of agonists. [(3)H]MK‐801 (2 nmol L(−1)) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, with an IC(50) value of ~19 nmol L(−1). The non‐linear Scatchard plots, biphasic inhibition by open channel blockers, and bi‐exponential kinetics of [(3)H]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [(11)C]GMOM are discussed. John Wiley and Sons Inc. 2019-02-19 /pmc/articles/PMC6381215/ /pubmed/30784206 http://dx.doi.org/10.1002/prp2.458 Text en © 2019 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Metaxas, Athanasios
van Berckel, Bart N. M.
Klein, Pieter J.
Verbeek, Joost
Nash, Emily C.
Kooijman, Esther J. M.
Renjaän, Véronique A.
Golla, Sandeep S. V.
Boellaard, Ronald
Christiaans, Johannes A. M.
Windhorst, Albert D.
Leysen, Josée E.
Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title_full Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title_fullStr Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title_full_unstemmed Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title_short Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[(3)H](3)methoxy phenyl)‐N′‐methylguanidine ([(3)H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist
title_sort binding characterization of n‐(2‐chloro‐5‐thiomethylphenyl)‐n′‐(3‐[(3)h](3)methoxy phenyl)‐n′‐methylguanidine ([(3)h]gmom), a non‐competitive n‐methyl‐d‐aspartate (nmda) receptor antagonist
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381215/
https://www.ncbi.nlm.nih.gov/pubmed/30784206
http://dx.doi.org/10.1002/prp2.458
work_keys_str_mv AT metaxasathanasios bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT vanberckelbartnm bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT kleinpieterj bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT verbeekjoost bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT nashemilyc bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT kooijmanestherjm bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT renjaanveroniquea bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT gollasandeepsv bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT boellaardronald bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT christiaansjohannesam bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT windhorstalbertd bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist
AT leysenjoseee bindingcharacterizationofn2chloro5thiomethylphenyln33h3methoxyphenylnmethylguanidine3hgmomanoncompetitivenmethyldaspartatenmdareceptorantagonist